{
    "organizations": [],
    "uuid": "467b59b7ecd2d2c1507c0efbb3e665d134d4bda0",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-indias-strides-shasun-gets-us-fda/brief-indias-strides-shasun-gets-u-s-fda-nod-for-cinacalcet-hydrochloride-tablets-idUSFWN1S900W",
    "ord_in_thread": 0,
    "title": "BRIEF-India's Strides Shasun Gets U.S. FDA Nod For Cinacalcet Hydrochloride Tablets",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 2 (Reuters) - Strides Shasun Ltd:\n* STRIDES SHASUN RECEIVES USFDA APPROVAL FOR CINACALCET HYDROCHLORIDE TABLETS\n* PRODUCT WILL BE MANUFACTURED AT COâ€™S ORAL DOSAGE FACILITY AT PUDUCHERRY\n* PRODUCT WILL BE MARKETED BY STRIDES PHARMA INC IN THE U.S. MARKET Source text - bit.ly/2re6dw0 Further company coverage:\n ",
    "published": "2018-05-02T12:43:00.000+03:00",
    "crawled": "2018-05-03T12:34:46.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "stride",
        "shasun",
        "ltd",
        "stride",
        "shasun",
        "receives",
        "usfda",
        "approval",
        "cinacalcet",
        "hydrochloride",
        "tablet",
        "product",
        "manufactured",
        "co",
        "oral",
        "dosage",
        "facility",
        "puducherry",
        "product",
        "marketed",
        "stride",
        "pharma",
        "inc",
        "market",
        "source",
        "text",
        "company",
        "coverage"
    ]
}